Status:
UNKNOWN
Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women
Lead Sponsor:
Mansoura Integrated Fertility Center
Conditions:
Polycystic Ovary Syndrome
Infertility
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
Polycystic ovarian syndrome (PCOS) is a condition characterized by infertility, infrequent periods and amenorrhea or irregular bleeding plus anovulatory infertility. Clomid is the standard first drug ...
Detailed Description
To test whether CC co- treatment with chronic low dose HP uFSH versus lirizole plus chronic low dose HP uFSH in CC resistant PCOS will yield comparable results in terms of, ovulation rate, lower folli...
Eligibility Criteria
Inclusion
- CC resistant PCOS
- Infertile
- Females
- Age 18-38
Exclusion
- Hyperprolactinaemia
- Cushing syndrome
- Adult onset adrenal hyperplasia
- Age \> 38
- Other infertility factors in the couple than PCOS: male factor,tubal factor,edometriosis
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2014
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01793038
Start Date
March 1 2013
End Date
September 1 2014
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura Integrated fertility center
Al Mansurah, Dekahlia, Egypt